Amicus Therapeutics receives U.S. approval for Fabry disease drug

U.S. health regulators on Friday approved Amicus Therapeutics' Galafold, the first oral therapy to treat Fabry disease, a rare, sometimes fatal condition in which accumulation of fat damages several organs.

from Reuters: Health https://ift.tt/2AVXExX
via IFTTT

• Tweet
• Share
• Share
• Share
• Share